Welcome to our dedicated page for Medirom Healthcare Technologies news (Ticker: MRM), a resource for investors and traders seeking the latest updates and insights on Medirom Healthcare Technologies stock.
MEDIROM Healthcare Technologies Inc. (MRM) operates at the intersection of traditional wellness services and cutting-edge digital health solutions, offering a unique blend of relaxation salons, preventative healthcare technology, and luxury beauty services. This news hub provides investors and industry observers with timely updates on MEDIROM's strategic initiatives, financial performance, and technological advancements in Japan's evolving healthcare sector.
Access centralized updates covering earnings reports, product launches, partnership announcements, and operational developments across MEDIROM's three core segments. The curated news collection enables efficient tracking of the company's expansion in health-tech innovation, including smart tracking devices and corporate wellness solutions, while maintaining its leadership in Japan's relaxation salon market.
Key updates include developments from subsidiary MEDIROM MOTHER Labs Inc., progress in data-driven healthcare platforms, and integration of body-heat-powered wearable technology. Users gain insight into how the company balances its established wellness network with digital transformation strategies to address modern healthcare challenges.
Bookmark this page for streamlined access to verified MEDIROM news, featuring official press releases and third-party analysis. Regularly updated content supports informed decision-making for stakeholders monitoring the convergence of healthcare services and technological innovation in Asian markets.
MEDIROM Healthcare Technologies (Nasdaq CM: MRM) has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) with a 1.875% annual interest rate. JPY200 million of the loan funds will be used to repay the indebtedness of MEDIROM Mother Labs Inc., a subsidiary and loan guarantor.
The remaining funds will support general working capital, including the development of Mother Bracelet. CEO Koji Eguchi stated that this financing strengthens their financial position and provides additional support for the Mother Bracelet development.
MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs, has made a second investment in Mother Labs' Series A financing. The investment values Mother Labs at a pre-money valuation of JPY9 billion (approximately US$60 million) as of March 13, 2025.
This follow-up investment comes after Mr. Hayami's initial Series A investment in December 2024. As a committed senior executive, Hayami shares MEDIROM's corporate philosophy, vision, and commitment to future growth potential. His background includes founding INIT Co., in 1996, serving as Executive Officer at transcosmos inc. in 2004, and founding Wise, Inc. in 2014. In 2024, he was appointed Chairman of MEDIROM Rehab Solutions and Chief Business Officer of MEDIROM Mother Labs.
MEDIROM Healthcare Technologies (Nasdaq: MRM) released preliminary, unaudited financial results for FY2024 under Japanese GAAP. The company reported total revenue of JPY8.2 billion ($52.6 million), a JPY1.4 billion increase from 2023, driven by salon sales to investors, increased store outsourcing revenue, and revenue from their newly acquired rehabilitation business.
The company's adjusted operating income reached JPY160 million ($1.0 million), marking a significant improvement from the previous year's operating loss. Key performance indicators showed 308 total salons as of December 2024, serving 945,395 customers with an average sales per customer of JPY7,111 ($45.2) and a repeat ratio of 76.3%.
These results exclude approximately JPY140 million in offering-related expenses from their second public equity offering in December 2024. The company notes these preliminary results are subject to final audit under U.S. GAAP standards.
MEDIROM Healthcare Technologies Inc. (MRM) has released its December 2024 Key Performance Indicators. The company reported 80,764 total customers served with sales per customer of JPY 7,384, showing an increase from JPY 7,271 in December 2023. The customer repeat ratio stood at 77.6% with an operation ratio of 45.9%.
The company's salon network comprised 308 locations with 283 providing comparable data. In their Health Tech Business segment featuring the Lav® app, MEDIROM has expanded its presence in the specific health guidance program market, reaching 97 corporate insurance association contracts and 8,816 cumulative users by December 2024.
MEDIROM Healthcare Technologies (NASDAQ: MRM) has completed all corporate capital registration procedures for its offering of 2,860,000 common shares represented by American Depositary Shares. The offering, which closed on December 11, 2024, generated gross proceeds of approximately $5 million.
Following the registration completion on January 14, 2025, the company's registered corporate capital and capital reserve amounts are 365,019,146 yen and 365,019,145 yen respectively, with 7,994,451 total outstanding shares. This marks the first follow-on registered underwritten public offering in the United States by a Japanese company listed solely on a U.S. stock exchange.
The proceeds will be used for working capital and general corporate purposes, including potential investments, acquisitions, strategic collaborations to expand customer base, and development and marketing of new services.
MEDIROM Healthcare Technologies (NASDAQ: MRM) announces that its subsidiary, MEDIROM MOTHER Labs, is providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet, to TOPPAN's Electronics Division.
The MOTHER Bracelet is promoted as the world's first 24/7 recharge-free smart tracker, powered by temperature difference between body and air. It tracks five health metrics: heart rate, surface body temperature, step count, sleep, and calories burned. The REMONY system combines this bracelet with a gateway for automatic data synchronization and real-time management.
TOPPAN will implement this technology to monitor employee health, particularly focusing on workers living alone or on solo assignments, aiming for early detection and response to health abnormalities. This implementation aligns with TOPPAN's initiatives to ensure employee physical and mental well-being.
MEDIROM Healthcare Technologies (NASDAQ: MRM) released its November 2024 KPIs, showing mixed performance in its salon operations. Total customers served increased to 75,760 from 75,290 year-over-year, with sales per customer rising slightly to JPY 7,055 from JPY 7,045. The repeat ratio remained stable at 77.5%, while operation ratio improved to 44.6% from 43.9%.
In the Health Tech Business segment, the company's Lav® app, which provides health guidance programs, continued to expand. As of November 2024, MEDIROM has secured contracts with 95 corporate insurance associations, and the cumulative number of Lav® app users reached 8,515 individuals.
MEDIROM MOTHER Labs, a subsidiary of MEDIROM Healthcare Technologies (NASDAQ: MRM), has raised JPY260.3 million (approximately $1.7 million) in its ongoing Series A financing round at a pre-money valuation of JPY9 billion ($58.6 million). NFES Technologies leads the investment, joined by M3, Inc., Elematec , and other investors.
The company's flagship product, the MOTHER Bracelet®, has received orders for over 25,000 units through B2B channels between July and October 2024. This innovative fitness tracker generates electricity from body heat, requiring no charging, and monitors fitness levels, sleep patterns, pulse, and body temperature. The company is targeting markets including hospitals, nursing homes, and gyms.
MEDIROM Healthcare Technologies (NASDAQ: MRM) has closed its public offering of 2,860,000 American Depositary Shares at $1.75 per share, raising approximately $5 million in gross proceeds before deducting underwriting discounts and expenses. The company granted underwriters a 45-day option to purchase up to 429,000 additional shares for over-allotments. ThinkEquity serves as the sole book-running manager for the offering.
The company, which operates over 300 wellness salons across Japan, plans to use the proceeds for working capital and general corporate purposes, including potential investments, acquisitions, strategic collaborations to expand its customer base, and marketing of new services.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announced that two senior executives of its subsidiary MEDIROM MOTHER Labs have invested in Mother Labs' Series A financing. The investment was made at a pre-money valuation of JPY9 billion (approximately USD $59,000,000) as of December 1, 2024.
The investing executives are Issei Homan, Chief Technology Officer, and Yasuhiro Hayami, Chief Business Officer of Mother Labs. Both executives share MEDIROM's corporate philosophy, vision, and commitment to future growth potential. Homan brings experience from founding Aratana Inc. and working with ZOZOUSED Inc., while Hayami's background includes founding INIT Co., and executive roles at transcosmos inc.
